Skip to main content
SpringerLink
Log in

Afatinib/osimertinib/pembrolizumab

Lack of efficacy and type 1 diabetes mellitus: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bansal S, et al. New-Onset Type 1 Diabetes in an Elderly Female on Pembrolizumab. American Journal of the Medical Sciences 363: 371-372, No. 4, Apr 2022. Available from: URL: http://doi.org/10.1016/j.amjms.2021.10.024

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib/osimertinib/pembrolizumab. Reactions Weekly 1905, 21 (2022). https://doi.org/10.1007/s40278-022-14411-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-14411-5

Search

Navigation